• OPEN AN ACCOUNT
Indian Indices
Nifty
25,509.70 -87.95
(-0.34%)
Sensex
83,311.01 -148.14
( -0.18%)
Bank Nifty
57,554.25 -272.80
( -0.47%)
Nifty IT
35,337.60 63.05
( 0.18%)
Global Indices
Nasdaq
46,931.02 -400.98
(-0.85%)
Dow Jones
6,741.06 -76.23
(-1.12%)
Hang Seng
50,848.14 635.87
(1.27%)
Nikkei 225
9,736.38 -40.70
(-0.42%)
Forex
USD-INR
88.68 -0.07
(-0.08%)
EUR-INR
101.96 -0.30
(-0.29%)
GBP-INR
115.92 -0.66
(-0.56%)
JPY-INR
0.58 0.00
(0.22%)

EQUITY - MARKET SCREENER

Aurobindo Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524804
INE406A01037
365.9334533
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AUROPHARMA
33.07
66829.23
EPS(TTM)
Face Value()
Div & Yield %
34.49
1
0
 

As on: Nov 06, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,140.55 -10.45 52510 33.07
Stock Price Details
Open Price() 1,152.95
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,155.90
Today's Low () 1,121.70
52-Week High () 1416.2
152-Week Low () 994.35
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.00
Eps 34.49
Book Value 365.9334533
Market Cap (.Cr) 66,829.23
Face Value 1
Market Lot 1
AGM Date Sep
Book Closure Date Aug
ISIN No. INE406A01037


News
Aurobindo Pharma consolidated net profit rises 3.80% in the September 2025 quarter
Aurobindo Pharma Ltd - Aurobindo Pharma Limited - Updates
Aurobindo Pharma Ltd soars 1.15%
Aurobindo Pharma announces board meeting date
Aurobindo Pharma gains after arm incorporates new subsidiary in Chile
Aurobindo Pharma Ltd - Announcement under Regulation 30 (LODR)-Acquisition
Aurobindo Pharma Ltd - Announcement under Regulation 30 (LODR)-Acquisition
Aurobindo Pharma Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication
Aurobindo Pharma Ltd - Aurobindo Pharma Limited - Copy of Newspaper Publication
Aurobindo Pharma Ltd - Aurobindo Pharma Limited - Certificate under SEBI (Depositories and Participants) Regulations, 2018 :
More
Corporate Details
Incoporation Year   : 1986
Chairman : M R Kumar
Bussiness Group : Indian Private
Registered Office
Aurobindo Pharma Ltd
Plot No 2 Maitrivihar,
Behind Maithri Vanam Ameerpet,
Hyderabad,
Telangana-500038
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-40-23736370
Fax:91-40-23747340
Fax:91-22-66317458
E-Mail : cs@aurobindo.com; investorgrievances@aurobindo.com
URL : http://www.aurobindo.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Midcap
  • CNX 500
  • Nifty Midcap50
  • CNX Midcap
  • CNX Pharma
  • CNX 200
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi